A blood-based prognostic biomarker in IBD

OBJECTIVE: We have previously described a prognostic transcriptional signature in CD8 T cells that separates patients with IBD into two phenotypically distinct subgroups, termed IBD1 and IBD2. Here we sought to develop a blood-based test that could identify these subgroups without cell separation, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Biasci, Daniele, Lee, James C, Noor, Nurulamin M, Pombal, Diana R, Hou, Monica, Lewis, Nina, Ahmad, Tariq, Hart, Ailsa, Parkes, Miles, McKinney, Eoin F, Lyons, Paul A, Smith, Kenneth G C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691955/
https://www.ncbi.nlm.nih.gov/pubmed/31030191
http://dx.doi.org/10.1136/gutjnl-2019-318343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691955/
https://www.ncbi.nlm.nih.gov/pubmed/31030191
http://dx.doi.org/10.1136/gutjnl-2019-318343

Ejemplares similares